“An important cautionary note, however, is that the accompanying financial models are much less well developed, particularly with regard to risk sharing,” he continues. “That said, I think medicine as a whole has a terrific opportunity here to fundamentally redesign patient care for the benefit of all.”
According to Ed Herzig, MD, MACR, ACR board member, “The ACR has begun the process of developing an advanced alternative payment model that is specialty and physician focused. Attending this meeting gave us the opportunity to learn from others who are developing models for their own specialties. This meeting has helped inform us about the path forward and some of its pitfalls.
“There was a session at the Annual Meeting in San Diego on Sunday morning [Nov. 5] to discuss both MIPS and the APM,” he notes.
The ACR Board of Directors met on Nov. 4 in conjunction with the Annual Meeting and approved the continued development of a rheumatology-specific APM. The ACR’s APM workgroup will begin the next steps toward submitting the APM to CMS for review.
The 2017 ACR/ARHP Annual Meeting was held Nov. 3–8 in San Diego.
